Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal-Plus vs Basal-Bolus vs SSRI in Hospitalized T2DM
NCT00979628Phase 4Completed
- Start
- Jan 2010
- Primary completion
- Mar 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine, insulin glulisine in type 2 diabetes mellitus (T2DM). Started Jan 2010; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00979628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979628.